Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Lykke M. Ornbjerg, Louise Linde, Stylianos Georgiadis, Simon H. Rasmussen, Ulf Lindström, Johan Askling, Brigitte Michelsen, Daniela Di Giuseppe, Johan K. Wallman, Karel Pavelka, Jakub Zavada, Michael J. Nissen, Gareth T. Jones, Heikki Relas, Laura Pirila, Ziga Rotar, Arni Jon Geirsson, Bjorn Gudbjornsson, Eirik K. Kristianslund, Irene Van Sder Horst-BruinsmaAnne Gitte Loft, Karin Laas, Florenzo Iannone, Addolorata Corrado, Adrian Ciurea, Maria J. Santos, Helena Santos, Catalin Codreanu, Nurullah Akkoc, Ozgul S. Gunduz, Bente Glintborg, Mikkel Ostergaard, Merete Lund Hetland

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number152081
JournalSeminars in Arthritis and Rheumatism
Volume56
Number of pages11
ISSN0049-0172
DOIs
Publication statusPublished - Oct 2022
MoE publication typeA1 Journal article-refereed

Bibliographical note

Correction: Volume 58, Article Number 152141
DOI: 10.1016/j.semarthrit.2022.152141
Published: FEB 2023

Fields of Science

  • Axial spondyloarthritis
  • TNF-inhibitors
  • Predictors
  • Ankylosing spondylitis disease activity score
  • ANKYLOSING-SPONDYLITIS
  • PSORIATIC-ARTHRITIS
  • TREATMENT RESPONSE
  • ALPHA DRUGS
  • REMISSION
  • THERAPY
  • CONTINUATION
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this